Suppr超能文献

基质金属蛋白酶的表达与 SARS-CoV-2 诱导的肺病理学和 K18-hACE2 小鼠细胞外基质重塑有关。

Matrix Metalloproteinases Expression Is Associated with SARS-CoV-2-Induced Lung Pathology and Extracellular-Matrix Remodeling in K18-hACE2 Mice.

机构信息

Israel Institute for Biological Research, Ness Ziona P.O. Box 19, Israel.

Department of Biological Regulation, Weizmann Institute of Science, Herzel 234, Rehovot P.O. Box 26, Israel.

出版信息

Viruses. 2022 Jul 26;14(8):1627. doi: 10.3390/v14081627.

Abstract

The COVID-19 pandemic caused by the SARS-CoV-2 infection induced lung inflammation characterized by cytokine storm and fulminant immune response of both resident and migrated immune cells, accelerating alveolar damage. In this work we identified members of the matrix metalloprotease (MMPs) family associated with lung extra-cellular matrix (ECM) destruction using K18-hACE2-transgenic mice (K18-hACE2) infected intranasally with SARS-CoV-2. Five days post infection, the lungs exhibited overall alveolar damage of epithelial cells and massive leukocytes infiltration. A substantial pulmonary increase in MMP8, MMP9, and MMP14 in the lungs post SARS-CoV-2 infection was associated with degradation of ECM components including collagen, laminin, and proteoglycans. The process of tissue damage and ECM degradation during SARS-CoV-2 lung infection is suggested to be associated with activity of members of the MMPs family, which in turn may be used as a therapeutic intervention.

摘要

由 SARS-CoV-2 感染引起的 COVID-19 大流行导致肺部炎症,其特征是细胞因子风暴和常驻及迁移免疫细胞的剧烈免疫反应,加速了肺泡损伤。在这项工作中,我们使用 K18-hACE2 转基因小鼠(K18-hACE2)鉴定了与肺细胞外基质(ECM)破坏相关的基质金属蛋白酶(MMPs)家族成员,这些小鼠经鼻腔感染了 SARS-CoV-2。感染后 5 天,肺部表现出上皮细胞的整体肺泡损伤和大量白细胞浸润。SARS-CoV-2 感染后肺部 MMP8、MMP9 和 MMP14 的大量增加与 ECM 成分的降解有关,包括胶原、层粘连蛋白和糖胺聚糖。SARS-CoV-2 肺部感染过程中的组织损伤和 ECM 降解与 MMPs 家族成员的活性有关,这反过来可能被用作治疗干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d75/9332556/6019ed06723a/viruses-14-01627-g001.jpg

相似文献

2
A longitudinal molecular and cellular lung atlas of lethal SARS-CoV-2 infection in K18-hACE2 transgenic mice.
EBioMedicine. 2024 Jan;99:104932. doi: 10.1016/j.ebiom.2023.104932. Epub 2023 Dec 19.
4
Development of transgenic models susceptible and resistant to SARS-CoV-2 infection in FVB background mice.
PLoS One. 2022 Jul 26;17(7):e0272019. doi: 10.1371/journal.pone.0272019. eCollection 2022.
5
Comparative pathology of the nasal epithelium in K18-hACE2 Tg mice, hACE2 Tg mice, and hamsters infected with SARS-CoV-2.
Vet Pathol. 2022 Jul;59(4):602-612. doi: 10.1177/03009858211071016. Epub 2022 Jan 29.
8
Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
mBio. 2022 Feb 22;13(1):e0290621. doi: 10.1128/mbio.02906-21. Epub 2022 Jan 25.
9
Mild and Severe SARS-CoV-2 Infection Induces Respiratory and Intestinal Microbiome Changes in the K18-hACE2 Transgenic Mouse Model.
Microbiol Spectr. 2021 Sep 3;9(1):e0053621. doi: 10.1128/Spectrum.00536-21. Epub 2021 Aug 11.

引用本文的文献

1
A novel biomarker of COVI-19: MMP8 emerged by integrated bulk RNAseq and single-cell sequencing.
Sci Rep. 2024 Dec 28;14(1):31086. doi: 10.1038/s41598-024-82227-8.
2
New Insights into the Link between SARS-CoV-2 Infection and Renal Cancer.
Life (Basel). 2023 Dec 28;14(1):52. doi: 10.3390/life14010052.
3
Novel mechanism of the COVID-19 associated coagulopathy (CAC) and vascular thromboembolism.
Npj Viruses. 2023;1. doi: 10.1038/s44298-023-00003-3. Epub 2023 Oct 18.
4
Redefining metalloproteases specificity through network proteolysis.
Trends Mol Med. 2024 Feb;30(2):147-163. doi: 10.1016/j.molmed.2023.11.001. Epub 2023 Nov 29.
5
Mast cell-mediated immune regulation in health and disease.
Front Med (Lausanne). 2023 Aug 17;10:1213320. doi: 10.3389/fmed.2023.1213320. eCollection 2023.
7
Auraptene Has Antiviral Activity against Human Coronavirus OC43 in MRC-5 Cells.
Nutrients. 2023 Jun 29;15(13):2960. doi: 10.3390/nu15132960.
9
Role of matrix metalloproteinases in multi-system inflammatory syndrome and acute COVID-19 in children.
Front Med (Lausanne). 2022 Dec 5;9:1050804. doi: 10.3389/fmed.2022.1050804. eCollection 2022.
10
Circulating tissue inhibitor of metalloproteinases 1 (TIMP-1) at COVID-19 onset predicts severity status.
Front Med (Lausanne). 2022 Nov 29;9:1034288. doi: 10.3389/fmed.2022.1034288. eCollection 2022.

本文引用的文献

1
An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS-CoV-2.
EMBO Mol Med. 2022 Nov 8;14(11):e16109. doi: 10.15252/emmm.202216109. Epub 2022 Sep 23.
4
MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients.
Biomed Pharmacother. 2021 Oct;142:112067. doi: 10.1016/j.biopha.2021.112067. Epub 2021 Aug 20.
5
Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection.
Proc Natl Acad Sci U S A. 2021 Jul 20;118(29). doi: 10.1073/pnas.2101555118.
6
Post covid 19 pulmonary fibrosis. Is it real threat?
Indian J Tuberc. 2021 Jul;68(3):330-333. doi: 10.1016/j.ijtb.2020.11.003. Epub 2020 Nov 10.
7
Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 Infection.
Nano Lett. 2021 Jun 9;21(11):4774-4779. doi: 10.1021/acs.nanolett.1c01284. Epub 2021 May 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验